Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $456.0 million.

  • GE HealthCare Technologies' Shares Outstanding (Weighted Average) changed 0.0% to $456.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $456.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $456.0 million for FY2025, which is 0.0% changed from last year.
  • Latest data reveals that GE HealthCare Technologies reported Shares Outstanding (Weighted Average) of $456.0 million as of Q4 2025, which was down 0.0% from $457.0 million recorded in Q3 2025.
  • GE HealthCare Technologies' Shares Outstanding (Weighted Average)'s 5-year high stood at $457.0 million during Q2 2024, with a 5-year trough of $454.0 million in Q1 2022.
  • In the last 4 years, GE HealthCare Technologies' Shares Outstanding (Weighted Average) had a median value of $455.5 million in 2023 and averaged $455.5 million.
  • In the last 5 years, GE HealthCare Technologies' Shares Outstanding (Weighted Average) changed by 0.0% in 2023 and then surged by 44.05% in 2024.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Shares Outstanding (Weighted Average) stood at $454.0 million in 2022, then rose by 0.22% to $455.0 million in 2023, then rose by 0.22% to $456.0 million in 2024, then changed by 0.0% to $456.0 million in 2025.
  • Its last three reported values are $456.0 million in Q4 2025, $457.0 million for Q3 2025, and $457.0 million during Q2 2025.